Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether the use of a sequential high dose chemotherapy is more effective than conventional dose (i.e. 4 cycles of cisplatin, etoposide, and bleomycin [PEB]) in patients with metastatic poor prognosis germ cell tumors.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02161692
Study type Interventional
Source Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Contact
Status Completed
Phase Phase 2
Start date December 1996
Completion date April 2009

See also
  Status Clinical Trial Phase
Completed NCT00231582 - High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II Phase 2
Terminated NCT02900248 - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Terminated NCT02577172 - Testicular Cancer and Aerobic and Strength Training N/A
Completed NCT03403777 - Avelumab in Refractory Testicular Germ Cell Cancer. Phase 2
Completed NCT02890030 - The Platinum Study Comparison Group
Recruiting NCT05264337 - Lymphedema After Urologic Surgery
Active, not recruiting NCT03426865 - Role of Axumin PET Scan in Germ Cell Tumor
Completed NCT00001270 - Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma Phase 1
Completed NCT02459132 - High-Intensity Aerobic Interval Training in Testicular Cancer Survivors N/A
Completed NCT06309732 - GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT) Phase 2
Terminated NCT02499952 - Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors Phase 2
Recruiting NCT02304575 - Quality of Life Among Testicular Cancer Survivors N/A
Withdrawn NCT02492360 - Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy N/A
Completed NCT04122430 - Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours
Recruiting NCT02229916 - Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS
Completed NCT02966509 - Engagement of Patients With Advanced Cancer N/A
Recruiting NCT02341989 - Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer Phase 3
Completed NCT05056688 - Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors N/A
Terminated NCT05229900 - A Study of SGN-ALPV in Advanced Solid Tumors Phase 1
Completed NCT00123773 - Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence Phase 2